Formosa LaboratoriesTPE:4746 +1.68%70 Days Payable is 30.84 as of Dec. 2025, which is 7% below its 10-year median of 33.28. GuruFocus rates TPE:4746 with a GF Score™ of 70/100 and a GF Value™ of NT$98.89 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 922 Drug Manufacturers companies, Formosa Laboratories ranks worse than 87.2% on this metric.
The historical rank and industry rank for Formosa Laboratories's Days Payable or its related term are showing as below:
TPE:4746'
s Days Payable Range Over the Past 10 Years
Min: 28.59 Med: 33.28 Max: 42.77
Current: 32.93
During the past 13 years, Formosa Laboratories's highest Days Payable was 42.77. The lowest was 28.59. And the median was 33.28.
TPE:4746's Days Payable is ranked worse than 87.2% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs TPE:4746: 32.93
Formosa Laboratories's Days Payable
increased
from Dec. 2024 (27.75) to Dec. 2025 (30.84).
It may suggest that Formosa Laboratoriesdelayed paying its suppliers.
Formosa Laboratories Days Payable Related Terms
Formosa Laboratories Days Payable Historical Data
* Premium members only.
The historical data trend for Formosa Laboratories's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Formosa Laboratories's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Formosa Laboratories Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Formosa Laboratories's Days Payable distribution charts can be found below:
* The bar in red indicates where Formosa Laboratories's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Formosa Laboratories's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Formosa Laboratories (TPE:4746) has a Days Payable of 30.84 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Formosa Laboratories and its competitors. This is near median its historical median of 33.28. Over the past decade, Formosa Laboratories' Days Payable has ranged from 28.59 to 42.77. According to the industry distribution chart, Formosa Laboratories ranks #804 out of 922 companies in the Drug Manufacturers industry, placing it in the top 87.2%.
Is Formosa Laboratories' Days Payable too high?
Formosa Laboratories' current Days Payable of 30.84 is near median its 10-year median of 33.28. Over the past 10 years, this metric has ranged from a low of 28.59 to a high of 42.77. The Drug Manufacturers industry median Days Payable is 90.84. Formosa Laboratories' value of 30.84 is 66% below this industry median. Based on the distribution chart, Formosa Laboratories ranks #804 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Formosa Laboratories has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Formosa Laboratories' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Formosa Laboratories ranks #804 out of 922 companies for Days Payable. This places Formosa Laboratories in the lower half of its industry. The industry median Days Payable is 90.84. Formosa Laboratories' value of 30.84 is 66% below this benchmark. Historically, Formosa Laboratories' own Days Payable has ranged from 28.59 to 42.77 over the past decade. While the company's 10-year median is 33.28 vs. the industry median of 90.84, Formosa Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Formosa Laboratories's current Days Payable of 30.84 is 66% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Formosa Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Formosa Laboratories's current Days Payable is 30.84, which is near median its own 10-year median of 33.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Formosa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Formosa Laboratories (TPE:4746) is currently considered Possible Value Trap. The stock's GF Value™ is NT$98.89, compared to a current price of NT$54.40 — trading 45% below its estimated fair value. The current Days Payable is 30.84, which is near median its 10-year median of 33.28 and 66% below the Drug Manufacturers industry median of 90.84. Formosa Laboratories' overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Formosa Laboratories (TPE:4746), the current Days Payable is 30.84 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Formosa Laboratories (TPE:4746) Overvalued in 2026?
Based on GuruFocus' analysis, Formosa Laboratories stock appears to be undervalued.
The current stock price of NT$54.40 is trading 45% below its estimated GF Value™ of NT$98.89.
GuruFocus considers Formosa Laboratories to be Possible Value Trap.
Key valuation signals for TPE:4746:
Days Payable: 30.84 (near median its 10-year median of 33.28)
GF Value™: NT$98.89 vs. price of NT$54.40 (45% below fair value)
Industry Position: 66% below the Drug Manufacturers median (#804 of 922)
No single metric tells the full story. See the TPE:4746 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Formosa Laboratories Inc is mainly engaged in the wholesale and manufacturing of active pharmaceutical ingredients, as well as ultraviolet absorbers. The company geographically operates in India, Taiwan, Netherlands, Switzerland, Germany, Japan, China, Canada, United States, and Others.
70GF Score
Get the complete analysis for TPE:4746
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4746 has been successfully added to your 
